- Oculodentodigital Syndrome (ODD) is a rare genetic disorder affecting the eyes, teeth, and fingers, often caused by mutations in the GJA1 gene. Diagnosis typically involves genetic testing and symptom-based clinical evaluations
- The market is driven by increased awareness and early diagnosis of rare genetic conditions, along with advancements in genomic research and personalized medicine
- North America is expected to dominate the oculodentodigital syndrome market due to strong healthcare infrastructure, higher diagnostic capabilities, and increased investment in rare disease research
- Asia-Pacific is expected to be the fastest growing region in the oculodentodigital syndrome market during the forecast period due to increasing healthcare expenditure, improved access to genetic testing, and rising awareness of rare disease
- Dental anomalies segment is expected to dominate the market with a market share of 41% due to its the high prevalence of dental defects among patients with ODDS. These anomalies, such as defective enamel and malformed teeth, are one of the most noticeable and impactful symptoms of the syndrome, leading to an increased demand for dental treatments and restorative procedures
